Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma

Published:2001-10 Issue:10 Volume:12 Page:1439-1443
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Machover D.,Delmas-Marsalet B.,Misra S.C.,Gumus Y.,Goldschmidt E.,Schilf A.,Frénoy N.,Emile J.-F.,Debuire B.,Guettier C.,Farrokhi P.,Boulefdaoui B.,Norol F.,Parquet N.,Ulusakarya A.,Jasmin C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/10/1439/19478865/12-10-1439.pdf

Reference17 articles.

1. Effective salvage therapy for lymphoma with cisplalin in combination with high-dose ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

2. Treatment of relapsed non-Hodgkin’s lymphomas with dexamethasone. high-dose cytarabine, and cisplatin before marrow transplantation;Press;J Clin Oncol,1991

3. High-dose chemotherapy followed by autologous bone marrow transplantation vs. dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin’s lymphoma with partial response to front-line chemotherapy: A prospective randomised Italian mullicenlcr study;Martelli;J Clin Oncol,1996

4. Parma International Protocol: Pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation;Philip;Blood,1991

5. Antitumor activity of a new platinum complex, oxalato (trans-l-l,2-diaminocyclohcxanc) platinum (II) New experimental data;Tashiro;Biomed Pharmacother,1989

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase IB Study of Oral Selinexor in Combination with Rituximab and Platinum Chemotherapy in Patients with Relapsed/Refractory B-Cell Lymphoma—Final Analysis;Cancers;2024-07-26

2. Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group;Annals of Hematology;2024-03-09

3. Navigating between Scylla and Charybdis: A roadmap to do better than Pola-RCHP in DLBCL;Cancer Treatment Reviews;2024-03

4. Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group;Cancers;2022-03-30

5. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers;Cancers;2021-02-25